2012-09-26T19:24:30-05:00 2011-12-31 ERNST & YOUNG US LLP 401 CONGRESS AVENUE SUITE 1800 AUSTIN TX 78701 990 2011-01-01 741809687 Gulf Coast Regional Blood Center % MELISSA A FISHER GULF 7137901200 1400 LA CONCHA LANE HOUSTON TX 77054 Melissa A Fisher 2012-09-25 5124789881 2011 2016-02-24 21:20:13Z Melissa A Fisher 1400 LA CONCHA LANE HOUSTON TX 77054 118100732 false X WWW.GIVEBLOOD.ORG X 1974 TX TO MAINTAIN AND SUPPORT A REGIONAL BLOOD CENTER TO PRIMARILY SERVICE THE NEEDS OF THE PATIENTS AND DONORS IN HARRIS AND SURROUNDING COUNTIES. 27 25 741 176 0 344029 171985 106017475 102298245 182762 134682 1380104 1613994 107924370 104218906 102000 28750 0 0 43635675 42776116 0 0 82735 55013102 54910048 98750777 97714914 9173593 6503992 77773861 85244860 18734706 19705350 59039155 65539510 X TO MAINTAIN AND SUPPORT A REGIONAL BLOOD CENTER TO PRIMARILY SERVICE THE NEEDS OF THE PATIENTS AND DONORS IN HARRIS AND SURROUNDING COUNTIES. true false 80344116 28750 88809553 Transfusion Services - Gulf Coast Regional Blood Center collected over 333,000 units of blood and blood components from voluntary donors. We shipped more than 406,000 units to hospitals and surgical centers. During 2011, Gulf Coast Regional Blood Center received $319,859 of in-kind contributions in support of its programs. This support is in addition to the $88,828,805 of revenue shown above. 8885164 13488661 The Blood Center performs 13 different tests on every unit of blood collected. Our Consultation and Reference Laboratory serves as a compatibility testing service and provides suitable, safe and effective blood and blood components for transfusion to patients in over 100 facilities. The laboratory also functions as a reference laboratory for clients and area hospitals performing and evaluating a wide variety of tests to resolve complex serological patient problems. Consultation and Reference also registers rare donors with the American Rare Donor Program (ARDP) and provides and receives rare units through ARDP. 1414191 1347763 The mission of the National Marrow Donor Program (NMDP) is to educate and register donors for the NMDP Registry, to promote the awareness of the life-saving need for marrow and peripheral blood donations from adult donors to patients awaiting transplant, and to raise funds for donor testing, typing and recruitment. 128670 193625 90772141 true true false false false false false false false true false false false false true true true false false false false false false true false false false true true true false false false false false false false false false false false false false false false true true false false false true 21 0 true 741 true false false false false false true true false false false false X 27 25 false false false false false false false true true false false true true true true true true true true true true X MELISSA A FISHER 7137916205 1400 LA CONCHA LANE HOUSTON TX 77054 David M McClanahan 2.0 X 0 0 0 Karen Tellepsen 2.0 X 0 0 0 John D Milam MD 2.0 X 0 0 0 Greg Bernica 2.0 X 0 0 0 J David Bessman MD 1.0 X 0 0 0 Arthur Bracey MD 2.0 X 0 0 0 Gerard J Colman 1.0 X 0 0 0 Robert S Craig 2.0 X 0 0 0 William H Fleming III MD 1.0 X 0 0 0 Lewis E Foxhall MD 1.0 X 0 0 0 A Tomas Garcia MD 1.0 X 0 0 0 William S Gilmer MD 1.0 X 0 0 0 Richard J Hausner MD 2.0 X 0 0 0 Alexander Indrikovs MD 1.0 X 0 0 0 Kenneth L Mattox MD 1.0 X 0 0 0 Khush Nariman 1.0 X 0 0 0 Ethan A Natelson MD 2.0 X 0 0 0 Jospeh H Peck Jr 2.0 X 0 0 0 Guru N Reddy MD 1.0 X 0 0 0 Duane K Rossmann 1.0 X 0 0 0 Linda B Russell 1.0 X 0 0 0 James G Slack 2.0 X 0 0 0 Charles L Sowell III 1.0 X 0 0 0 Michael E Speer 1.0 X 0 0 0 Rick Townsend 1.0 X 0 0 0 Brian G Gannon 50.0 X X 432826 0 42620 Susan N Rossmann MD 50.0 X X 310747 0 36171 Caron Cousins-Baker 50.0 X 234936 0 26891 Doug McClain 50.0 X 257968 0 41338 Melissa A Fisher 50.0 X 225895 0 31709 Elaine Gordon 50.0 X 147232 0 18424 Beth Hartwell 50.0 X 227576 0 23334 Bart Block 50.0 X 137037 0 26792 Cheri Jennings 50.0 X 125477 0 18519 Gretchen Sassone 50.0 X 123880 0 12445 2223574 0 278243 17 false true false Ernst Young LLP 3712 Solutions CHICAGO IL 60677 Audit & Tax SERVICES 111200 1 25123 35827 111035 171985 SERVICE FEES, BLOOD, & BLOOD COMPONENTS 621991 87353251 87353251 Laboratory services 621511 13488661 13488661 NATL MARROW DONOR FEES & CONTRIBUTION 621991 1262708 1262708 CELLULAR THERAPIES FEES 325414 193625 193625 102298245 147408 147408 0 0 13769000 50872 13767844 64754 1156 -13882 -12726 -12726 121865 35827 49228 72637 72637 0 0 Misc. Service Fees-Pick-up/Delivery charges 900099 1049099 1049099 Proceeds from Group Purchase Rebates 900099 356244 356244 Other Miscellaneous Revenue 900099 136014 136014 1541357 104218906 103839602 207319 0 28750 28750 0 0 1462373 803652 658721 0 33323605 31516669 1738230 68706 1960672 1775607 182662 2403 3502862 3272208 225030 5624 2526604 2369859 152596 4149 0 109606 109606 115395 115395 0 0 0 162542 34342 128200 6022004 6022004 5000797 4449820 549187 1790 1142403 1126117 16286 0 2924822 2336662 588160 955274 941157 14104 13 0 207876 184967 22859 50 133148 133148 0 3745219 3202855 542364 1306754 1306754 Reagents 15240262 15240262 Collection and Lab Supplies 15845811 15845481 330 Bone Marrow Program 1414191 1414191 Imports 207538 207538 376406 376406 97714914 90772141 6860038 82735 10580383 15220502 8599812 12365367 29000 0 11617017 10189084 0 0 0 0 0 0 6778284 7309380 882412 1088877 59414761 30280699 29885899 29134062 8491790 8992700 0 0 0 0 0 0 909264 944888 77773861 85244860 8714560 10551848 0 0 88943 99771 9450522 8727558 0 0 0 0 475681 326173 0 0 5000 0 18734706 19705350 X 58531501 64955438 507654 584072 0 0 59039155 65539510 77773861 85244860 X 6503992 -3637 X false true true X false X 518267 1059743 511642 344029 171985 2605666 90172330 100551252 104929778 107455039 103961467 507069866 90690597 101610995 105441420 107799068 104133452 509675532 15250 0 5000 0 20250 0 0 0 15250 0 5000 0 20250 509655282 372586 471795 113383 143342 147408 1248514 20000 20000 372586 471795 133383 143342 147408 1268514 170931 0 170931 91063183 102253721 105574803 107942410 104280860 511114977 0.99714 0.99669 0.00248 0.00292 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 4017891 4017891 25197147 8283309 16913838 7565046 5459639 2105407 21805684 16087751 5717933 828993 450000 378993 29134062 0 0 104218906 97714914 6503992 -3637 -3637 6500355 104473321 -3637 319859 49228 365450 104107871 111035 111035 104218906 98084001 319859 49228 369087 97714914 97714914 Fin 48/ASC 740 Audit Footnote Schedule D, Part X The Blood Center has not identified or recorded any liability for uncertain tax positions for 2011 or 2010. RECONCILIATION OF INCOME FORM 990, SCHEDULE D, PART XII SCHEDULE D, PART XII, LINE 2D FUNDRAISING EXPENSES $49,228 SCHEDULE D, PART XII, LINE 4B RESTRICTED CONTRIBUTIONS $111,035 RECONCILIATION OF EXPENSES FORM 990, SCHEDULE D, PART XIII, 2D FUNDRAISING EXPENSES $49,228. Gala 157692 35827 121865 14151 1740 22160 4180 6997 0 157692 35827 121865 14151 1740 22160 4180 6997 49228 72637 true HIGH SCHOOL SCHOLARSHIPS 15 26000 MT AND SBB SCHOLARSHIPS 3 2750 Description of Organization's Procedures for Monitoring the Use of Grants Form 990, Schedule I, Part III Grants are to promote research and development in all scientific, medical/technical and administrative aspects of blood banking; including but not limited to immunohematology, transfusion therapy, tissue typing and related activities. Progress reports of research accomplished should be comprehensive and indicate the significance of the study. The progress reports should include an accounting of monies spent in performance of the research and should be presented in the prescribed format. Reports of unpublished research are confidential. Deadlines for Progress reports are as follows: One Grant Funded (no renewal) - January 15 of the following funding year. Competitive Renewal - Must accompany grant renewal application. If progress reports are not received prior to the January meeting of Gulf Coast Regional Blood Center Board of Trustees or if research is deemed unsatisfactory by the GCRBC Board of Trustees, GCRBC has the right to terminate the grant and reclaim any unused funds. X true true X X X false true false false false true false true false Brian G Gannon 327275 0 78006 0 27545 0 33711 0 8909 0 475446 0 0 0 Susan N Rossmann MD 257300 0 31444 0 22003 0 27603 0 8568 0 346918 0 0 0 Caron Cousins-Baker 191919 0 23977 0 19040 0 20413 0 6478 0 261827 0 0 0 Doug McClain 211691 0 26609 0 19668 0 27936 0 13402 0 299306 0 0 0 Melissa A Fisher 185062 0 23727 0 17106 0 24964 0 6745 0 257604 0 0 0 Elaine Gordon 137439 0 6902 0 2891 0 12746 0 5678 0 165656 0 0 0 Beth Hartwell 212467 0 12064 0 3045 0 17073 0 6261 0 250910 0 0 0 Bart Block 122256 0 14371 0 410 0 14147 0 12645 0 163829 0 0 0 Supplemental Compensation Information Schedule J, Part III Question 1A: Gross-up payments are provided on vehicle allowance and vehicle use for executives and disability insurance for the CEO and CFO. Question 4B: Brian Gannon, CEO, and Dr. Susan Rossmann, Chief Medical Officer, participate in an Executive Deferred Compensation (457(F)) nonvested plan. Earning and contribution to the Plan for Mr. Gannon and Dr. Rossmann for 2011 were $6,711 and $3,531 respectively. Question 6A and 7: All employees participate in a bonus plan that is dependent on achieving company-wide goals. One goal is tied to Net Revenue over Expenses. Some executives also have individual goals that impact bonus plan amounts. Payout percentages for executives are set by the compensation committee and are approved by the compensation committee and board prior to payment for all executives. HACKBERRY CULTURAL EDUC FACILITIES FINANCE CORP 752237898 2007-12-14 8100000 CONSTRUCT MOBILE OPERATION COMPLEX false false false 0 0 8246684 0 0 0 120882 0 0 7694325 0 0 2009 false false true true false false false false 0.00000 0.00000 0.00000 true false true false 0 false 0 false false X SEE SCHEDULE O 0 SIGNIFICANT NEW PROGRAM SERVICES/OTHER PROGRAM SERVICES Form 990, Part III, Questions 2 and 4D Therapeutic apheresis services The Blood Center performs specialized cellular collections by apheresis for patients with specific types of cancers, infectious diseases, and autoimmune disorders. The collected products are further modified by biomedical companies for reinfusion to the patient as a means of disease treatment or development of novel therapeutics and advanced treatment regimens. PROCESS USED BY GOVERNING BODY TO REVIEW/APPROVE FORM 990 Form 990, Part VI, Question 11B Gulf Coast Regional Blood Center's (GCRBC) Finance Committee is the primary governing body responsible for the oversight of GCRBC's audited financial statements, 990 and 990-T tax returns. The draft tax returns, once reviewed and approved by management, are provided to the finance committee for their review and they are discussed with management. Once the finance commitee approves the draft tax returns, copies of the entire draft tax returns are provided to the entire Board of Trustees for their review. The finance committee acts on behalf of the full Board. The finance committee chair will report on the review of the draft tax returns to the full Board of Trustees. DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICTS OF INTEREST Form 990, Part VI, Question 12C Our conflict of interest policy which has been approved by the board is provided to all Board members, officers and management staff. They are required to complete and sign the policy statement requiring that persons comply with the disclosure requirements and voting and membership prohibitions set in the policy. As part of this policy, they are required to complete and sign a conflict of interest questionnaire. This questionnaire requires that persons listed above identify and disclose all affiliations or interests with facilities they or immediate family members have a relationship with. These questionnaires are reviewed by the CEO. Our conflict of interest policy addresses duties to disclose financial interests, duty to disclose relationships with certain facilities and procedures for determining whether a potential conflict of interest exists. Further, if a potential conflict of interest is identified, our policy addresses procedures for presenting the facts, investigation of potential conflicts by a disinterested person or committee and a decision process to determine if the transaction is in the best interest of GCRBC, for GCRBC's own benefit, fair and reasonable to GCRBC and/or in the best interest of the welfare of the community. Our policy defines potential violations of the policy such as failure to disclose. The policy defines records of procedures that contain identified conflicts of interest, voting prohibitions and records of voting by individual board members. PROCESS FOR DETERMINING EXECUTIVE COMPENSATION Form 990, Part VI, Question 15A All executive compensation is reviewed and approved by the compensation committee and the Board. Compensation amounts are determined based on independent surveys and comparable data to organizations our size for non-profits and other blood centers. This process was last undertaken from December 2011 through January 2012. PROCESS FOR DETERMINING ALL OTHER MANAGEMENT COMPENSATION FORM 990, PART VI, QUESTION 15B All other management positions' (directors) compensation are based on compensation reviews performed by our Human Resources Department. The HR Department obtains independent surveys for these positions and other comparable data to determine their recommendation of the compensation. All salary recommendations are reviewed and approved by the executives. This process was last undertaken from December 2011 through February 2012. AVAIL OF GOV DOCS, CONFLICT OF INTEREST POLICY & FIN STMTS TO GEN PUBLIC FORM 990, PART VI, QUESTION 19 All governing documents, conflicts of interest policy and financial statements are available upon request. Tax form 990 and 990-T are also available upon request and are also available via Guidestar's website. Our website has a link to the Guidestar website. OTHER CHANGES IN NET ASSETS FORM 990, PART XI, LINE 5 UNREALIZED GAIN $ (3,637) TOTAL PROCEEDS OF ISSUE SCHEDULE K, PART II, LINE 3 TOTAL PROCEEDS OF ISSUE INCLUDES ORIGNAL ISSUE OF $8,100,000 PLUS INVESTMENT INTEREST OF $146,684. CAPITAL EXPENDITURES FROM PROCEEDS SCHEDULE K, PART II, LINE 10 UNSPENT PROCEEDS IN THE AMOUNT OF $431,478 WERE USED TO PAY DOWN THE LOAN PRINCIPAL BALANCE AFTER ALL CONSTRUCTION ACTIVITIES WERE COMPLETE. TOTAL CONSTRUCTION EXPENSE FOR THE PROJECT WAS $9,218,000. HOWEVER, THE BLOOD CENTER WAS ABLE TO PAY FOR APPROXIMATELY $1,500,000 FROM OUR OWN FUNDS. AS A RESULT, WE HAD EXCESS LOAN FUNDS ON-HAND AND THOSE FUNDS $431,478 WERE USED TO PAY DOWN THE PRINCIPAL BALANCE OF THE DEBT IN NOVEMBER OF 2009. Blood Corporation of America 1400 La Concha Houston TX 77054 740247034 Inactive TX NA CORPORATION 0 0 1.00000 false false false false false false false false false false false false false false false false false false